A Phase II Study of SHR-2173 Injection in Patients With Myasthenia Gravis
Clinical trial NCT07622342 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07622342
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2027-09-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.